American Well (NYSE:AMWL – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it compare to its competitors? We will compare American Well to similar businesses based on the strength of its earnings, risk, institutional ownership, analyst recommendations, profitability, dividends and valuation.
Earnings and Valuation
This table compares American Well and its competitors revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| American Well | $211.23 million | -$95.70 million | -3.12 |
| American Well Competitors | $345.82 million | -$24.15 million | 11.30 |
American Well’s competitors have higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Insider & Institutional Ownership
56.0% of American Well shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 12.8% of American Well shares are held by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
American Well has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, American Well’s competitors have a beta of 1.11, indicating that their average share price is 11% more volatile than the S&P 500.
Profitability
This table compares American Well and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| American Well | -27.03% | -24.32% | -17.91% |
| American Well Competitors | -749.77% | -27.84% | -15.02% |
Analyst Recommendations
This is a breakdown of current ratings and price targets for American Well and its competitors, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| American Well | 1 | 5 | 1 | 0 | 2.00 |
| American Well Competitors | 457 | 1542 | 2763 | 90 | 2.51 |
American Well currently has a consensus price target of $12.30, indicating a potential upside of 14.42%. As a group, “Healthcare Technology” companies have a potential upside of 55.83%. Given American Well’s competitors stronger consensus rating and higher probable upside, analysts clearly believe American Well has less favorable growth aspects than its competitors.
Summary
American Well competitors beat American Well on 9 of the 13 factors compared.
American Well Company Profile
American Well Corporation, which operates as Amwell, provides digital healthcare technology and services. Its platform helps health systems, health plans and other healthcare organizations offer virtual care and connect patients with clinicians. Amwell’s offerings include telehealth visits and tools for behavioral health, chronic care, primary care and specialty services. Its technology is designed to support care across digital and in-person settings, with clinical services delivered by healthcare providers and partner organizations.
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.
